Evidence map›Paper›PMID 40037561›Full record

ArticleAge and ageing2025

Common occurrence of atrophic gastritis in an ageing non-hospitalised population: an autopsy study.

Pekka Karhunen, Sari Tuomisto, Sirkka Goebeler, Mika Martiskainen, Eloise Kok

Abstract read
In one paragraph

Article in Age and ageing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Randomized controlled trial of an oral gastrin receptor antagonist for the treatment of postmenopausal osteoporosis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Trial
  2. Article
  3. Article
  4. Microorganisms · 2025
    Article
  5. Observational
  6. Review
  7. Vaccines · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pekka KarhunenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0000-0002-0320-571X
Sari TuomistoFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Sirkka GoebelerFinnish Institute for Health and Welfare, Helsinki, Uusimaa, Finland.
Mika MartiskainenFinnish Institute for Health and Welfare, Helsinki, Uusimaa, Finland.
Eloise KokFaculty of Medicine and Health Technology, Tampere University, Tampere, Pirkanmaa, Finland.

Funding

AtheroRemo ProjectEuropean Union 7th Framework Program 201668Finnish Cultural FoundationFinnish Foundation for Cardiovascular Research and the Jane and Aatos Erkko FoundationFinnish Parkinson's FoundationMedical Research Fund of Tampere University HospitalPirkanmaa Regional Fund of the Finnish Cultural Foundation
6 · The paper itself

Abstract

backgroundAtrophic gastritis-the end stage of chronic gastritis-is an asymptomatic disease due to Helicobacter pylori infection causing decreased vitamin B12 and folate absorption, which may lead to severe haematological and neuropsychological disorders including Alzheimer's disease. The diagnosis requires endoscopy and biopsies from symptomatic patients, explaining why its true prevalence in the population is not well-known.

objectiveWe aimed to evaluate the prevalence of various stages of chronic gastritis in an autopsy series most closely representing the general population. SUBJECTS AND

methodsGastric mucosa samples were collected prospectively from out-of-hospital deaths included in the Tampere Sudden Death Study (n = 70, mean age 63, age range 22-91 years). Antrum and corpus samples were stained with a H. pylori antibody and staged histopathologically.

resultsChronic gastritis with or without atrophic changes was detected in 40% of the cases. The proportion of healthy mucosa decreased age-dependently from 71.4% among individuals aged <50 years to 43.5% among the oldest individuals (>70 years), and that of chronic non-atrophic gastritis from 21.4% to 8.7%. In contrast, the prevalence of atrophic gastritis was 27.1% and increased in the age groups from 7.1% to 47.8% (P = .019) among the oldest individuals, showing a strong association (P < .0001) with H. pylori immunopositivity.

conclusionsAtrophic gastritis is a common feature of the ageing stomach, which is observed in every second individual aged 70+ years, showing a strong association with H. pylori immunopositivity. Atrophic gastritis may be a more common risk factor in old age for diseases associated with low serum B12 and folate levels than has been previously known.

Indexed as

AgingGastric MucosaGastritis, AtrophicHelicobacter InfectionsAdultAgedAged, 80 and overAge FactorsAutopsyBiopsyChronic DiseaseFemaleHelicobacter pyloriHumansMaleMiddle AgedatrophicchronicgastritisH. pyloriolder people

Identifiers

PMID40037561
PMCPMC11879357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.